Treatment of refractory immune cytopenias in the 21st century-how safe is rituximab?
Ravindranath, Yaddanapudi
2005-09
Citation: Ravindranath, Yaddanapudi (2005)."Treatment of refractory immune cytopenias in the 21st century-how safe is rituximab?." American Journal of Hematology 80(1): 92-93. <http://hdl.handle.net/2027.42/48687>
Abstract: No Abstract.
ISSN: 0361-8609, 1096-8652
DOIs: http://dx.doi.org/10.1002/ajh.20464
PMID: 16138348
URI: http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16138348&dopt=citation
Handle: http://hdl.handle.net/2027.42/48687
Show full item record

PDF file
Download
Name: 20464_ftp.pdf
Size: 224.7KB
Format: PDF

This item appears in the following Collection(s)


Search Deep Blue

Advanced Search

Browse by

My Account

Information


MLibrary logo